Summary
Novo Nordisk India has launched Awiqli, the first once-weekly basal insulin for diabetes, aiming to reduce injections from daily to weekly for the over 101 million people living with diabetes in India.
Novo Nordisk Launches Once-Weekly Basal Insulin Awiqli in India for Diabetes Treatment
HyperFast News
Related news
Novo Nordisk Launches Once-Weekly Basal Insulin 'Awiqli' in India Amid Rising Diabetes Rates
14 Sept 2026, 5:49 pm · News
Novo Nordisk launches once-weekly insulin shot in India at Rs 261, targeting more diabetics
14 Sept 2026, 5:49 pm · News
Novo Nordisk Launches Awiqli, World's First Weekly Basal Insulin, in India
14 Sept 2026, 5:49 pm · News
